Dialysis world news


Argos Therapeutics' Arcelis™ Immunotherapy for Renal Cell Carcinoma ... - Sacramento Bee PDF Print
Sacramento BeeBy Argos Therapeutics CHICAGO, Oct. 1 -- /PRNewswire/ -- Argos Therapeutics announced that its Arcelis immunotherapy for renal cell carcinoma (RCC), ...Argos Therapeutics' Arcelis(TM) Immunotherapy for Renal Cell Carcinoma

... read more

 
Argos Therapeutics' Arcelis(TM) Immunotherapy for Renal Cell Carcinoma ... - SYS-CON Media (press release) PDF Print
SYS-CON Media (press release)CHICAGO, Oct. 1 /PRNewswire/ -- Argos Therapeutics announced that its Arcelis immunotherapy for renal cell carcinoma (RCC), AGS-003, demonstrated favorable ...Argos Therapeutics' Arcelis™ Immunotherapy for Renal Cell Carcinoma

... read more

 
KAI Pharma initiates phase 1b study of KAI-4169 for secondary ... - pharmabiz.com PDF Print
pharmabiz.comMineral and bone disorders can be devastating to the health of ESRD patients with SHPT. KAI is committed to addressing this compelling medical need.

... read more

 
DaVita To Sell $1.45B Of Notes To Fund Debt-Refinance Plan - Wall Street Journal PDF Print
Wall Street JournalDaVita Inc. (DVA) plans to sell $1.45 billion of notes to fund the potential repurchase of up to $1.55 billion of debt as the operator of dialysis centers ...DaVita offering $1.45 billion in senior notes CanadianBusiness.comDaVita Inc. Commences Cash Tender Offers and Consent Solicitations for Any and

... read more

 
NKTI urges public to enroll in PhilHealth - Philippine Information Agency PDF Print
Philippine Information AgencyMembership to PhilHealth, according to NKTI Adult Nephrology Department chair Dr. Romina Danguilan, reduces hospital and treatment bills.

... read more

 
<< Start < Prev 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 Next > End >>

Page 1287 of 2630
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.